INTRODUCTION
This Amendment No. 2 to the Rule 13e-3 transaction statement on Schedule 13E-3, together with the exhibits hereto (as amended, this "Schedule 13E-3"), is being filed with the Securities and Exchange Commission (the "SEC") pursuant to Section 13(e) of the Securities Exchange Act of 1934, as amended (together with the rules and regulations promulgated thereunder, the "Exchange Act"), jointly by the following persons (each, a "Filing Person," and collectively, the "Filing Persons"): (i) Select Medical Holdings Corporation, a Delaware corporation (the "Company"), and the issuer of the common stock, par value $0.001 per share (the "Company Shares"), that is subject to the Rule 13e-3 transaction, (ii) Stallion Intermediate Corporation, a Delaware corporation ("Parent"), (iii) Stallion MergerSub Corporation, a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), (iv) Stallion Group Parent, LP, a Delaware limited partnership ("Group Parent"), (v) Stallion Group Parent GP, LLC, a Delaware limited liability company ("Stallion GP"), (vi) WCAS XIV, L.P., a Delaware limited partnership ("WCAS Fund XIV"), (vii) WCAS XIV Associates LLC ("Fund XIV GP"), (vii) WCAS Management, L.P., a Delaware limited partnership ("WCAS Management"), (viii) WCAS Management, LLC, a Delaware limited liability company ("WCAS Management GP"), and (ix)(a) Robert A. Ortenzio ("Mr. Ortenzio"), (b) Martin F. Jackson ("Mr. Jackson"), (c) Rocco A. Ortenzio Revocable Trust, dtd 8-14-2007, as amended, (d) Robert A. Ortenzio Descendants Trust, (e) Robert A. Ortenzio April 2014 Trust For Bryan A. Ortenzio, (f) Robert A. Ortenzio April 2014 Trust For Kevin M. Ortenzio and (g) Robert A. Ortenzio April 2014 Trust For Madeline G. Ortenzio (the Filing Persons described in clauses (a) and (c) through (g), the "Ortenzio Rollover Holders", and together with Mr. Jackson, the "Rollover Holders"). The Rollover Holders are Filing Persons of this Schedule 13E-3 because they are affiliates of the Company under the SEC rules governing "going-private" transactions.
This Schedule 13E-3 relates to (1) the Agreement and Plan of Merger, dated March 2, 2026 (including all exhibits and documents attached thereto, the "Merger Agreement"), by and among the Company, Parent and Merger Sub (collectively referred to as the "Parties"), which is attached hereto as Exhibit (d)(i); (2) the Rollover Agreements, each dated March 2, 2026 (collectively, the "Rollover Agreements"), by and between each Rollover Holder and Parent, which is attached hereto as Exhibits (d)(ii)-(d)(viii); (3) the Interim Investors Agreement, dated March 2, 2026 (the "Interim Investors Agreement"), by and among Parent, Merger Sub, WCAS XIV, L.P. a Delaware limited partnership ("WCAS"), Mr. Ortenzio and Mr. Jackson, which is attached hereto as Exhibit (d)(ix); (4) the Equity Commitment Letter, dated March 2, 2026 (the "Equity Commitment Letter"), by and between WCAS and Parent, which is attached hereto as Exhibit (d)(x); (5) the Limited Guaranty, dated March 2, 2026 (the "Limited Guaranty"), by and between WCAS and the Company, which is attached hereto as Exhibit (d)(xi); and (6) the Amended and Restated Debt Commitment Letter, dated March 14, 2026 (the "Amended and Restated Debt Commitment Letter"), by and among Parent, JPMorgan Chase Bank, N.A., Wells Fargo Bank, National Association, Wells Fargo Securities, LLC, Bank of America, N.A., BofA Securities, Inc., Deutsche Bank AG New York Branch, Deutsche Bank Securities Inc., Truist Bank, Truist Securities, Inc., Royal Bank of Canada, The Bank of Nova Scotia, Mizuho Bank, Ltd., Capital One, National Association, PNC Bank, National Association, PNC Capital Markets LLC and Fifth Third Bank, National Association (collectively, the "Debt Commitment Parties"), which is attached hereto as Exhibit (d)(xii).
On March 2, 2026, the Company entered into the Merger Agreement with Parent and Merger Sub, pursuant to which, subject to the terms and conditions thereof, Merger Sub will merge with and into the Company (the "Merger") with the Company surviving the Merger (the "Surviving Corporation"). The Surviving Corporation will be collectively owned, directly or indirectly, by Parent, WCAS, affiliates of WCAS, the Rollover Holders and any other person that may agree to become a Rollover Holder prior to the Effective Time (as defined below) of the Merger.
Subject to the terms and conditions set forth in the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each share of Company Shares issued and outstanding immediately prior to the Effective Time (other than (i) Company Restricted Shares (as defined in the Merger Agreement); (ii) each share of Company Shares owned by the Company as treasury stock or owned by any direct or indirect wholly-owned subsidiary of the Company, which shall be automatically canceled without any conversion thereof; (iii) each share of Company Shares otherwise owned by Parent or Merger Sub, any direct or indirect wholly-owned subsidiary of Parent, Merger Sub or the Rollover Holders or, to the extent designated in writing by Parent to the Company, any affiliate of Parent; and (iv) shares of Company Shares owned by stockholders of